Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials

@article{Ruan2016MoxifloxacinAG,
  title={Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials},
  author={Qiaoling Ruan and Qihui Liu and Feng Sun and Lingyun Shao and Jialin Jin and Shenglei Yu and Jingwen Ai and Bingyan Zhang and Wenhong Zhang},
  journal={Emerging Microbes & Infections},
  year={2016},
  volume={5},
  pages={e12-}
}
Moxifloxacin (MOX) and gatifloxacin (GAT) have exhibited promising mycobactericidal activity, and a number of clinical trials have been conducted in recent decades to compare the treatment efficacy of MOX-containing and/or GAT-containing regimens with the standard regimen. The aim of this meta-analysis for clinical trials of MOX- or GAT-containing regimens… CONTINUE READING